These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 24142686

  • 1. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG, Sarli B, Akpek M, Kaya EG, Yarlioglues M, Topsakal R, Lam YY.
    Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F.
    J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
    [Abstract] [Full Text] [Related]

  • 3. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K, Park TH.
    Trials; 2016 Nov 03; 17(1):530. PubMed ID: 27809882
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.
    Kawai K, Hata K, Takaoka H, Kawai H, Yokoyama M.
    Am Heart J; 2001 Jun 03; 141(6):925-32. PubMed ID: 11376305
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS.
    Echocardiography; 2005 Aug 03; 22(7):547-54. PubMed ID: 16060890
    [Abstract] [Full Text] [Related]

  • 12. Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.
    Cinquegrana G, D'Aniello L, Landi M, Spinelli L, Grande G, De Prisco F, Petretta M.
    J Card Fail; 2005 Apr 03; 11(3):213-9. PubMed ID: 15812750
    [Abstract] [Full Text] [Related]

  • 13. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L.
    Am Heart J; 2003 Feb 03; 145(2):292-9. PubMed ID: 12595847
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L.
    Circulation; 2000 Aug 01; 102(5):546-51. PubMed ID: 10920067
    [Abstract] [Full Text] [Related]

  • 15. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Sugioka K, Hozumi T, Takemoto Y, Ehara S, Ogawa K, Iwata S, Oe H, Matsumura Y, Otsuka R, Yoshiyama M, Yoshikawa J.
    Am Heart J; 2007 Jun 01; 153(6):1080.e1-6. PubMed ID: 17540213
    [Abstract] [Full Text] [Related]

  • 16. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL.
    Am J Cardiol; 2011 Apr 01; 107(7):1065-70. PubMed ID: 21296328
    [Abstract] [Full Text] [Related]

  • 17. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
    Patrianakos AP, Parthenakis FI, Mavrakis HE, Diakakis GF, Chlouverakis GI, Vardas PE.
    Am Heart J; 2005 Nov 01; 150(5):985. PubMed ID: 16290981
    [Abstract] [Full Text] [Related]

  • 18. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
    Fujimura M, Yasumura Y, Ishida Y, Nakatani S, Komamura K, Yamagishi M, Miyatake K.
    J Card Fail; 2000 Mar 01; 6(1):3-10. PubMed ID: 10746813
    [Abstract] [Full Text] [Related]

  • 19. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 20. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR.
    Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.